AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
Y
Yasser A. Aldhamen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.3K
Citations
20
h-index
34
i10-index
Yasser A. Aldhamen is an academic researcher from Michigan State University. The author has contributed to research in topics: Immune Cell Function and Interaction & Virus-based gene therapy research & Immunotherapy and Immune Responses. The author has an h-index of 20, co-authored 48 publications.
ORCID: 0000-0002-9560-8013Papers by this author
worksERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis
2018 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-018-30159-5
ERAP1 is a critical regulator of inflammasome-mediated proinflammatory and ER stress responses
2022 · BMC Immunology · 20 citations
https://doi.org/10.1186/s12865-022-00481-9
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-70321-w
Supplementary Material for: Autoimmune Disease-Associated Variants of Extracellular Endoplasmic Reticulum Aminopeptidase 1 Induce Altered Innate Immune Responses by Human Immune Cells
2015 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5127229
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat